Skip to main content
NCBI home page
Gut logoLink to Gut
. 1992 Jul;33(7):1006–1007. doi: 10.1136/gut.33.7.1006

Sulphasalazine induced renal failure.

A D Dwarakanath 1, J Michael 1, R N Allan 1
PMCID: PMC1379424  PMID: 1353741

Abstract

Two men with longstanding ulcerative colitis who were treated with sulphasalazine for several years and who developed chronic renal failure are reported. Renal biopsy specimens showed histological changes consistent with drug induced chronic intestinal nephritis. Extensive investigation made other causes of chronic renal failure unlikely. One of these patients underwent renal transplantation, the other has impaired but stable renal function.

Full text

PDF
1006

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbour V. M., Williams P. F. Nephrotic syndrome associated with sulphasalazine. BMJ. 1990 Oct 6;301(6755):818–818. doi: 10.1136/bmj.301.6755.818-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Calder I. C., Funder C. C., Green C. R., Ham K. N., Tange J. D. Comparative nephrotoxicity of aspirin and phenacetin derivatives. Br Med J. 1971 Nov 27;4(5786):518–521. doi: 10.1136/bmj.4.5786.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Das K. M., Eastwood M. A., McManus J. P., Sircus W. Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med. 1973 Sep 6;289(10):491–495. doi: 10.1056/NEJM197309062891001. [DOI] [PubMed] [Google Scholar]
  4. Henning H. V., Meinhold J., Eisenhauer T., Scheler F., Gröne H. J. Chronische interstitielle Nephritis nach Behandlung mit 5-Aminosalicylsäure. Dtsch Med Wochenschr. 1989 Jul 7;114(27):1091–1091. [PubMed] [Google Scholar]
  5. Ireland A., Priddle J. D., Jewell D. P. Acetylation of 5-aminosalicylic acid by isolated human colonic epithelial cells. Clin Sci (Lond) 1990 Jan;78(1):105–111. doi: 10.1042/cs0780105. [DOI] [PubMed] [Google Scholar]
  6. Mehta R. P. Acute interstitial nephritis due to 5-aminosalicylic acid. CMAJ. 1990 Nov 15;143(10):1031–1032. [PMC free article] [PubMed] [Google Scholar]
  7. Novis B. H., Korzets Z., Chen P., Bernheim J. Nephrotic syndrome after treatment with 5-aminosalicylic acid. Br Med J (Clin Res Ed) 1988 May 21;296(6634):1442–1442. doi: 10.1136/bmj.296.6634.1442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pieniaszek H. J., Jr, Bates T. R. Capacity-limited gut wall metabolism of 5-aminosalicylic acid, a therapeutically active metabolite of sulfasalazine, in rats. J Pharm Sci. 1979 Oct;68(10):1323–1325. doi: 10.1002/jps.2600681036. [DOI] [PubMed] [Google Scholar]
  9. Ruf-Ballauf W., Hofstädter F., Krentz K. Akute interstitielle Nephritis durch 5-Aminosalicylsäure? Internist (Berl) 1989 Apr;30(4):262–264. [PubMed] [Google Scholar]
  10. von Mühlendahl K. E. Nephritis durch 5-Aminosalicylsäure. Dtsch Med Wochenschr. 1989 Feb 10;114(6):236–236. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES